File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0024-3205(93)90666-Q
- Scopus: eid_2-s2.0-0027263115
- PMID: 8100039
- WOS: WOS:A1993LF44100012
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Norepinephrine release in rat vas deferens. Effect of rauwolscine and BHT 920
Title | Norepinephrine release in rat vas deferens. Effect of rauwolscine and BHT 920 |
---|---|
Authors | |
Issue Date | 1993 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/lifescie |
Citation | Life Sciences, 1993, v. 53 n. 2, p. PL-19-PL-24 How to Cite? |
Abstract | Norepinephrine (NE) overflow from field-stimulated rat vas deferens preparations was quantified directly by electrochemical detection using high performance high liquid chromatography. The effect of agonist (BHT 920) and antagonist (rauwolscine) of prejunctional α2-adrenoceptors on NE overflow was assessed and compared with their effect on the smooth muscle mechanical response to field stimulation. Increasing the stimulation frequency from 2 to 30 Hz resulted in an increase in muscle tension together with an increase in NE overflow. Addition of 1 μM rauwolscine to the medium resulted in a significant increase in muscle contraction to field stimulation which reached a maximum at 5 Hz. On the other hand, NE overflow increased linearly with the frequency of stimulation within the range studied. Addition of 0.1 μM BHT 920 to the medium significantly decreased the amplitude of contractions at lower stimulation frequencies (2 to 10 Hz) but elicited no significant changes at high frequencies. BHT 920 did not significantly affect NE overflow for all range of stimulation frequency. The simultaneous recording of field-stimulation induced contractions and NE overflow indicates that in the rat vas deferens, rauwolscine acts like a pure α2 adrenoceptor antagonist at a prejunctional level. BHT 920 did not appear to affect selectively prejunctional α2 adrenoceptors but also may activate postjunctional α1 adrenoceptors. |
Persistent Identifier | http://hdl.handle.net/10722/171578 |
ISSN | 2023 Impact Factor: 5.2 2023 SCImago Journal Rankings: 1.257 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lapierre, N | en_US |
dc.contributor.author | Wilson, J | en_US |
dc.contributor.author | Bourreau, JP | en_US |
dc.contributor.author | Tougas, G | en_US |
dc.contributor.author | Kwan, CY | en_US |
dc.contributor.author | Daniel, EE | en_US |
dc.date.accessioned | 2012-10-30T06:15:47Z | - |
dc.date.available | 2012-10-30T06:15:47Z | - |
dc.date.issued | 1993 | en_US |
dc.identifier.citation | Life Sciences, 1993, v. 53 n. 2, p. PL-19-PL-24 | en_US |
dc.identifier.issn | 0024-3205 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171578 | - |
dc.description.abstract | Norepinephrine (NE) overflow from field-stimulated rat vas deferens preparations was quantified directly by electrochemical detection using high performance high liquid chromatography. The effect of agonist (BHT 920) and antagonist (rauwolscine) of prejunctional α2-adrenoceptors on NE overflow was assessed and compared with their effect on the smooth muscle mechanical response to field stimulation. Increasing the stimulation frequency from 2 to 30 Hz resulted in an increase in muscle tension together with an increase in NE overflow. Addition of 1 μM rauwolscine to the medium resulted in a significant increase in muscle contraction to field stimulation which reached a maximum at 5 Hz. On the other hand, NE overflow increased linearly with the frequency of stimulation within the range studied. Addition of 0.1 μM BHT 920 to the medium significantly decreased the amplitude of contractions at lower stimulation frequencies (2 to 10 Hz) but elicited no significant changes at high frequencies. BHT 920 did not significantly affect NE overflow for all range of stimulation frequency. The simultaneous recording of field-stimulation induced contractions and NE overflow indicates that in the rat vas deferens, rauwolscine acts like a pure α2 adrenoceptor antagonist at a prejunctional level. BHT 920 did not appear to affect selectively prejunctional α2 adrenoceptors but also may activate postjunctional α1 adrenoceptors. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/lifescie | en_US |
dc.relation.ispartof | Life Sciences | en_US |
dc.subject.mesh | Adrenergic Alpha-Agonists - Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Azepines - Pharmacology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Muscle, Smooth - Drug Effects - Innervation | en_US |
dc.subject.mesh | Norepinephrine - Secretion | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Wistar | en_US |
dc.subject.mesh | Vas Deferens - Drug Effects - Innervation | en_US |
dc.subject.mesh | Yohimbine - Pharmacology | en_US |
dc.title | Norepinephrine release in rat vas deferens. Effect of rauwolscine and BHT 920 | en_US |
dc.type | Article | en_US |
dc.identifier.email | Bourreau, JP:bourreau@hkucc.hku.hk | en_US |
dc.identifier.authority | Bourreau, JP=rp00389 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0024-3205(93)90666-Q | - |
dc.identifier.pmid | 8100039 | - |
dc.identifier.scopus | eid_2-s2.0-0027263115 | en_US |
dc.identifier.volume | 53 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.spage | PL | en_US |
dc.identifier.epage | 19 | en_US |
dc.identifier.isi | WOS:A1993LF44100012 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | LaPierre, N=10241646400 | en_US |
dc.identifier.scopusauthorid | Wilson, J=10239102200 | en_US |
dc.identifier.scopusauthorid | Bourreau, JP=7003927886 | en_US |
dc.identifier.scopusauthorid | Tougas, G=7006829238 | en_US |
dc.identifier.scopusauthorid | Kwan, CY=7201421224 | en_US |
dc.identifier.scopusauthorid | Daniel, EE=35474017600 | en_US |
dc.identifier.issnl | 0024-3205 | - |